Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Shana Arnhold

Physician Assistant, Medical Shawnee, KS Physician Assistant

NPI 1811189327 CMS profile 37184

7230 Renner Rd, Shawnee, KS 66217

Open in the dashboard

General payments

$81,881

687 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shana Arnhold of Shawnee, KS is reported in the CMS Open Payments database as having received $81,881 across 687 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,037 94
2024 General $19,909 144
2023 General $10,567 141
2022 General $22,439 153
2021 General $16,929 155

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shana Arnhold
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Shana Arnhold were reported at $12,037. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Shana Arnhold Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $16,929 $156 $41–$563 $132
2022 $22,439 $185 $55–$649 $149
2023 $10,567 $199 $58–$717 $160
2024 $19,909 $206 $62–$740 $164
2025 $12,037 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $50,410 244 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $19,640 124 payments
  3. Janssen Scientific Affairs, LLC $5,825 9 payments
  4. Janssen Biotech, Inc. $1,486 72 payments
  5. Lilly USA, LLC $438 22 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $418 26 payments
  7. Merck Sharp & Dohme Corporation $379 23 payments
  8. Pfizer Inc. $337 21 payments
  9. Regeneron Healthcare Solutions, Inc. $312 12 payments
  10. Nestle HealthCare Nutrition Inc. $309 15 payments
  11. Other $2,326 119 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,730 50 payments
  2. Travel and Lodging $14,483 51 payments
  3. Food and Beverage $12,288 580 payments
  4. Consulting Fee $4,328 2 payments
  5. Education $52 4 payments
Products named General payments · program years 2021–2025
  1. ENTYVIO $18,882 104 payments
  2. SKYRIZI Immunology $18,047 72 payments
  3. RINVOQ $15,091 90 payments
  4. HUMIRA $9,428 45 payments
  5. STELARA $7,004 70 payments
  6. TREMFYA $6,192 23 payments
  7. SKYRIZI Immunology $6,088 24 payments
  8. SIMPONI ARIA $555 31 payments
  9. SIMPONI $555 31 payments
  10. REMICADE $495 28 payments
  11. Other $6,145 333 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

442

Median for Physician Assistant: 241

Drug cost

$222,404

Median for Physician Assistant: $4,110

Branded share of claims

17.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Humira(Cf) Pen Adalimumab Brand 20 $209,225
Mesalamine Generic 26 $5,919
Colestipol Hcl Generic 32 $1,956
Lubiprostone Generic 11 $1,106
Lactated Ringers Ringer's Solution,lactated Brand 26 $1,023
Pantoprazole Sodium Generic 121 $821
Sucralfate Generic 12 $793
Omeprazole Generic 67 $598
Famotidine Generic 65 $395
Esomeprazole Magnesium Generic 18 $264

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$11,160

Medicare's payments for the services billed

Medicare patients

172

Average age 74

Services billed

185

109 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 55%
Chronic kidney disease 31%
Diabetes 30%
Ischemic heart disease 30%
Depression 29%
COPD 20%
Osteoporosis 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 28 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $11,749
$11,749 — —
ENTYVIO
  • Takeda Pharmaceuticals U.S.A., Inc. $5,067
$5,067 — —
RINVOQ
  • AbbVie, Inc. $1,701
$1,701 — —
OMVOH
  • Lilly USA, LLC $167
$167 — —
STELARA
  • Janssen Biotech, Inc. $154
$154 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 28 with Patron

Records

687 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record